Actinogen completes global patent family grant

• Final country (Brazil) patent granted for “Webster 7” family, which completes global grant process for this composition of matter patent family • The Xanamem molecule is now patent protected across all key pharmaceutical markets to cover any use in all diseases, including Alzheimer’s Disease (AD) and other neurological diseases • Composition of matter patent for Xanamem in most key markets can b